Alector to Present at Upcoming Virtual Healthcare Conferences
Alector, a clinical-stage biotechnology company pioneering immuno-neurology, has announced participation in several upcoming virtual investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Alector, a clinical-stage biotechnology company pioneering immuno-neurology, has announced participation in several upcoming virtual investor conferences. Key events include:
- Citi’s 16th Annual Biopharma Virtual Conference: Sept 8 at 11:35 a.m. ET and Sept 9 at 1:25 p.m. ET.
- Wells Fargo Virtual Healthcare Conference: Sept 10 at 2:00 p.m. ET.
- Morgan Stanley 19th Annual Global Healthcare Conference: Sept 13 at 11:45 a.m. ET.
Webcasts will be available on the Alector website, with replays for 30 days.
Details
News Market Reaction – ALEC
The recorded move for ALEC in the trading session of this news was +2.65%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in the following upcoming virtual investor conferences:
- Citi’s 16th Annual Biopharma Virtual Conference
- Wednesday, September 8, 2021 at 11:35 a.m. ET, What’s Next for Neurodegenerative Diseases Panel
- Thursday, September 9, 2021 at 1:25 p.m. ET, Fireside Chat
- The 2021 Wells Fargo Virtual Healthcare Conference
- Friday, September 10, 2021 at 2:00 p.m. ET, Corporate Presentation
- The Morgan Stanley 19th Annual Global Healthcare Conference
- Monday, September 13, 2021 at 11:45 a.m. ET, Fireside Chat
- Monday, September 13, 2021 at 11:45 a.m. ET, Fireside Chat
Live webcasts of each conference presentation will be available on the “Events & Presentations” page within the Investors section of the Alector website at http://investors.alector.com. Replays of the webcasts will be available on the Alector website for 30 days following the presentation dates.
About Alector
Alector is a clinical-stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Immuno-neurology targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. Alector has discovered and is developing a broad portfolio of innate immune system programs, designed to functionally repair genetic mutations that cause dysfunction of the brain’s immune system and enable the rejuvenated immune cells to counteract emerging brain pathologies. Alector’s immuno-neurology product candidates are supported by biomarkers and target genetically defined patient populations in frontotemporal dementia and Alzheimer’s disease. This scientific approach is also the basis for the company’s immuno-oncology programs. Alector is headquartered in South San Francisco, California. For additional information, please visit www.alector.com.
Alector Contacts
Michelle Corral
VP, Communications and Investor Relations
650-808-7016
michelle.corral@alector.com
1AB (media)
Dan Budwick
973-271-6085
dan@1abmedia.com
Argot Partners (investors)
Laura Perry/Eric Kasper
Argot Partners
212.600.1902
alector@argotpartners.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.